Related Experiment Video
Updated: Jan 20, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
Outcomes after Surgical Resection of Hilar Cholangiocarcinoma
Faisal Saud Dar1, Muhammad Atiq1, Neelam Shahzadi1
1Department of BPB Surgery and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan.
Insights
Surgical resection of hilar cholangiocarcinoma (hCCA) is complex. Experienced centers can achieve outcomes comparable to international standards, with 5-year survival rates of 60% recurrence-free and 39% overall.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Hilar cholangiocarcinoma (hCCA) presents significant surgical challenges.
- Long-term outcomes following hCCA resection are crucial for patient management.
Purpose of the Study:
- To report the long-term outcomes after surgical resection of hilar cholangiocarcinoma (hCCA).
Main Methods:
- A cohort study involving 24 patients who underwent surgical resection for hCCA.
- Outcomes assessed included 90-day morbidity and mortality, 5-year recurrence-free survival (RFS), and overall survival (OS).
Main Results:
- The 90-day mortality rate was 4.1%, with 66.7% experiencing morbidity.
- The 5-year recurrence-free survival (RFS) was 60%, and overall survival (OS) was 39%.
- Surgical procedures included various hepatectomy types, with some requiring portal vein resection.
Conclusions:
- Surgical resection of hCCA is technically demanding.
- Achieving outcomes comparable to international standards is feasible in experienced centers.
Objective:
To report long term outcomes after surgical resection of hilar cholangiocarcinoma (hCCA).
Study Design:
Cohort study.
Place And Duration Of Study:
Department of Liver Transplant and Hepatopancreaticobiliary Surgery, Shifa International Hospital, Islamabad, Pakistan, from October 2011 to April 2018.
Methodology:
A prospective review of maintained database of patients who underwent surgical resection for hCCA was performed. A total of 24 patients were included. Outcome was assessed, based upon 90-day morbidity and mortality, 5-year recurrence-free survival (RFS) and overall survival (OS).
Results:
Median age was 49 (23-73) years. Male to female ratio was 1.4:1. Median CA 19-9 level was 113 (2-1200) U/ml. Nine patients (37.5%) underwent right hepatectomy, six had right trisectionectomy (25%), three had central hepatectomy (12.5%) and left hepatectomy (12.5%) each, while three (12.5%) had other surgical procedures. In addition, two (8.3%) patients required portal vein resection and reconstruction. Median blood loss was 1350 (100-2000) ml. Median ICU stay was 4 (2-13) days, while hospital stay was 10 (6-32) days. Sixteen (66.7%) patients experienced at least one morbidity within 90 days, while 90-day mortality was 1/24 (4.1%). The overall recurrence rate was 6/18 (33.4%) and mortality was 9/18 (50%). The actuarial 5-year RFS was 60% and OS was 39%.
Conclusion:
hCCA remains a technically challenging surgical problem. Outcomes comparable to international standards can be achieved in experienced centres.
Related Concept Videos
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Kidney Transplant II: Surgical Procedure
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Urinary Tract Calculi VI: Surgical Management

